Cargando…
A meta-analysis of CXCL12 expression for cancer prognosis
BACKGROUND: CXCL12 (SDF1) is reported to promote cancer progression in several preclinical models and this is corroborated by the analysis of human tissue specimens. However, the relationship between CXCL12 expression and cancer survival has not been systematically assessed. METHODS: We conducted a...
Autores principales: | Samarendra, Harsh, Jones, Keaton, Petrinic, Tatjana, Silva, Michael A, Reddy, Srikanth, Soonawalla, Zahir, Gordon-Weeks, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520200/ https://www.ncbi.nlm.nih.gov/pubmed/28535157 http://dx.doi.org/10.1038/bjc.2017.134 |
Ejemplares similares
-
The Diagnostic Accuracy of Mutant KRAS Detection from Pancreatic Secretions for the Diagnosis of Pancreatic Cancer: A Meta-Analysis
por: Patel, Nikhil, et al.
Publicado: (2020) -
Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis”
por: Gordon-Weeks, Alex
Publicado: (2018) -
A core matrisome gene signature predicts cancer outcome
por: Yuzhalin, Arseniy E, et al.
Publicado: (2018) -
The safety of telemedicine clinics as an alternative to in-person preoperative assessment for elective laparoscopic cholecystectomy in patients with benign gallbladder disease: a retrospective cohort study
por: Urbonas, Tomas, et al.
Publicado: (2023) -
Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1β and hypoxia in small cell lung cancer
por: Zhu, Y M, et al.
Publicado: (2006)